There has not been enough data to look at diverse populations and how this medication impacts people who dont have the means compared to the typical population of folks who are currently accessing GLP-1s, she says

An anion exchange chromatography process for purifying a peptide or GLP-1 peptide from a mixture comprising said peptide or GLP-1 peptide and related impurities, comprising the step of: separating said peptide or GLP-1 peptide and said related impurities of said mixture by elution in a solution consisting essentially of an organic modifier, water, optionally a salt component, and optionally a buffer, with a linear or step gradient or isocratically in salt component and/or with a linear or step pH-gradient or at a constant pH-value, wherein the pH-gradient or pH-value should be in the range where said peptide or GLP-1 peptide has a negative local or overall net charge different from the local or overall negative net charge of said related impurities so as to remove said related impurities
- Administration: Subcutaneous injection, usually in the morning before eating
For most people, tirzepatide side effects are temporary and fade within a few weeks
Glucagon-Like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration